Begrivac 2010/2011 Injektionsvätska, suspension

국가: 스웨덴

언어: 스웨덴어

출처: Läkemedelsverket (Medical Products Agency)

유효 성분:

influensavirus A/California/7/2009 (H1N1)-deriverad stam (NYMC X-181), spjälkat virus, inaktiverat; influensavirus A/Perth/16/2009 (H3N2)-liknande stam (NYMC X-187, deriverad från A/Victoria/210/2009), spjälkat virus, inaktiverat; influensavirus B/Brisbane/60/2008-liknande stam (B/Brisbane/60/2008), ytantigen, inaktiverat

제공처:

Novartis Vaccines and Diagnostics GmbH

ATC 코드:

J07BB02

INN (국제 이름):

the influenza virus A/California/7/2009 (H1N1)-derived strain (NYMC X-181), spjälkat virus, inactivated; influenza virus, A/Perth/16/2009 (H3N2)-like strain (NYMC X-187, derived from A/Victoria/210/2009), spjälkat virus, inactivated; influenza virus, B/Brisbane/60/2008-like strain (B/Brisbane/60/2008), the surface antigen, inactivated

약제 형태:

Injektionsvätska, suspension

구성:

influensavirus A/California/7/2009 (H1N1)-deriverad stam (NYMC X-181), spjälkat virus, inaktiverat 15 mikrog Aktiv substans; influensavirus B/Brisbane/60/2008-liknande stam (B/Brisbane/60/2008), ytantigen, inaktiverat 15 mikrog Aktiv substans; influensavirus A/Perth/16/2009 (H3N2)-liknande stam (NYMC X-187, deriverad från A/Victoria/210/2009), spjälkat virus, inaktiverat 15 mikrog Aktiv substans

처방전 유형:

Receptbelagt

치료 영역:

spjälkat virus eller ytantigen

승인 상태:

Avregistrerad

승인 날짜:

1998-05-29